Elizabeth Moore

9PUBLICATIONS
26CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical biotechnology diagnostics (incl. biosensors)Cancer therapy (excl. chemotherapy and radiation therapy)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 16, 2026
Toxicity-Related Treatment Cessation in Newly Diagnosed Multiple Myeloma-Risk Factors and Survival: An Analysis From the APAC and ANZ Myeloma and Related Diseases Registry.

|Aug 19, 2024
Variation in immunoglobulin use and impact on survival in myeloma.

Khai Li Chai, Cameron Wellard, Ltp Thao

|Jul 05, 2024
The impact of biomarkers of malignancy (IMWG SLiM criteria) in myeloma in a real-world population: Clinical characteristics, therapy and outcomes from the Australian and New Zealand Myeloma and Related Diseases Registry (ANZ MRDR).

P Joy Ho, Elizabeth Moore, Cameron Wellard

|Dec 27, 2023
Real-world outcomes in relapsed refractory multiple myeloma patients exposed to three or more prior treatments: an analysis from the ANZ myeloma and related diseases registry.

Sueh-Li Lim, Cameron Wellard, Elizabeth Moore

|Aug 21, 2023
The prognostic impact of t(11;14) in multiple myeloma: A real-world analysis from the Australian Lymphoma Leukaemia Group (ALLG) and the Australian Myeloma and Related Diseases Registry (MRDR).

Kenneth Jc Lim, Cameron Wellard, Dipti Talaulikar

|Jul 12, 2022
Predictors of early mortality in multiple myeloma: Results from the Australian and New Zealand Myeloma and Related Diseases Registry (MRDR).

Zoe McQuilten, Cameron Wellard, Elizabeth Moore

Pageof 2

Frequent Collaborators

5 joint publications

Phoebe Joy Ho

5 joint publications

Simon James Harrison

4 joint publications

Zoe McQuilten

4 joint publications

Hang Quach